IP Library Granted Patent US 7,713,229
Granted Patent B2
US 7,713,229 · App. 10/981,830 · Granted May 11, 2010

Drug delivery pen with event notification means

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,713,229
App. No.
10/981,830
Granted
May 11, 2010
Kind
B2
Abstract

Devices, systems and methods are provided for drug delivery and the monitoring thereof. The systems include a drug delivery device, a holder for the drug delivery device when the device is not in use, a detector for detecting the presence of the drug delivery device within or close to the holder, and at least one algorithm for querying and prompting a user of the drug delivery device, wherein the at least one algorithm is activated upon removal of the drug delivery device from the holder.

Claims (48)

1. A drug delivery system comprising:

a microprocessor device including a glucose measurement unit;

a drug delivery device in communication with the microprocessor device, the drug delivery device configured to deliver a drug to a user;

a holder for the drug delivery device when the device is not in use;

a detector which detects the removal of the drug delivery device from the holder which causes the microprocessor device to prompt a user to conduct a glucose measurement with the glucose measurement unit, to provide a suggestion for dosage of the drug based on the user's entered input parameters and recommendation from a health care provider previously stored or entered into a memory of the microprocessor device.

2. The system of claim 1 , wherein the holder, the detector and the at least one algorithm are incorporated into a case for housing the system.

3. The system of claim 2 , wherein the microprocessor device turns on upon removal of the drug delivery device from the holder.

4. The system of claim 1 , further comprising means for communicating with a device for storing user information.

5. The system of claim 4 , wherein the user information comprises drug dosing information.

6. The system of claim 4 , means for communicating comprises wireless communication means.

7. The system of claim 1 , wherein the detector is selected from the group consisting of a mechanical switch, a magnetic switch, a density switch, a capacitive switch, an electrical sensor and an optical sensor.

8. The drug delivery system of claim 1 , further comprising: a wireless transmitter and receiver to transmit information regarding the user to a remote device.

9. The drug delivery system according to claim 8 wherein the information comprises data on blood glucose measurements of the user and delivery of the drug, which is selected from the group consisting of drug dosage information and timing of drug delivery.

10. An insulin injection system comprising:

a meter adapted for the measurement of glucose concentration in a blood sample, the meter comprising a microprocessor;

an insulin injector;

and a storage case for said insulin injector, the storage case including a detector that activates the meter upon removal of the insulin injector from the storage case, so that the meter prompts a user to conduct a glucose measurement with the meter and provide a suggestion for dosage of the drug based on the user's input parameters and a recommendation from a health care provider previously stored or entered into a memory of the microprocessor device.

11. The system of claim 10 , wherein the storage case comprises a storage space to house the meter.

12. The system of claim 10 , further comprising wireless communication unit to transmit and receive data to and from an external device.

13. The system of claim 12 , wherein the wireless communication unit comprises RF signals.

14. A method of monitoring the use of a drug delivery device, the method comprising:

storing the drug delivery device when the device is not in use;

removing the drug delivery device from storage;

detecting the removal of the drug delivery device from storage;

upon detecting removal of the drug delivery device from storage, prompting a user to conduct a blood glucose measurement with a blood glucose measurement unit;

upon the user conducting a blood glucose measurement, suggesting a dosage of drug to be delivered by the drug delivery device based on the user's input parameter and recommendations from the health care provider previously entered or stored in a memory of a microprocessor; and

requesting that the user enter a dosage actually delivered into the memory of the microprocessor.

15. The method of claim 14 , further comprising turning on the blood glucose measurement unit; and requesting that the user perform a glucose measurement.

16. The method of claim 14 , further comprising recording the time at which the drug delivery device is removed from storage.

17. The method of claim 14 , further comprising transmitting dosage actually delivered to a data storage device.

18. The method of claim 14 further comprising:

transmitting information on blood glucose measurements of the user to a remote device; and

transmitting information on dosage of drugs actually delivered to the remote device.

19. An insulin injection kit comprising:

a system comprising:

a meter adapted for the measurement of glucose concentration in a blood sample, the meter comprising a microprocessor;

an insulin injector; and

a storage case for said insulin injector, the storage case including a detector that activates the meter upon removal of the insulin injector from the storage case, so that the meter prompts a user to conduct a glucose measurement with the meter and provide a suggestion for dosage of the drug based on the user's input parameters and recommendation from a health care provider previously stored or entered into a memory of the microprocessor device;

a plurality of devices selected from the group consisting of lancers, lancets, needles and test strips; and

instructions for using the system.

20. A method of diabetes management for a user, the method comprising:

storing a drug delivery device in a storage case;

upon removal of the drug delivery device from the storage case, prompting a user with a microprocessor device to measure blood glucose value of the user, the microprocessor including a memory having a drug dosage delivery instructions previously stored in the memory from a health care provider based on at least one of a blood glucose value and user's input parameters;

upon the user conducting a measurement of blood glucose value, suggesting a drug dosage based on a measured blood glucose value and the instructions;

querying the user as to whether a dosage of drug was delivered upon removal of the drug delivery device from the storage case; and

verifying with the user of a dosage actually delivered to the user.

21. The method of claim 20 , further comprising transmitting data on blood glucose measurements made and drug dosage actually delivered to a remote device.

22. The method of claim 20 , further comprising receiving data drug dosage delivery instructions from a remote device.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2005
From: VEIT, ERIC D.; BYLUND, ADAM; WEBER, BARRY; LUTHER, PETER; MCCLUSKEY, JOSEPH; BIDEGAINBERRY, JEAN
To: LIFESCAN, INC.
Reel/Frame 015963/0215 →